<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952415</url>
  </required_header>
  <id_info>
    <org_study_id>PFTTTTS</org_study_id>
    <nct_id>NCT04952415</nct_id>
  </id_info>
  <brief_title>the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome</brief_title>
  <official_title>the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome in Shengjing Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shengjing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal medicine in China is still a new, young discipline, and the development is very rapid.&#xD;
      After nearly 10 years of development, the clinical diagnosis and treatment guidelines of some&#xD;
      complicated twin diseases has been established. Among them, twin-to-twin-transfusion syndrome&#xD;
      (TTTS) is serious disease in twin pregnancy, and the factors affecting prognosis after&#xD;
      fetoscopic laser surgery are part of the study. Through this study, the investigators expect&#xD;
      to achieve better prediction indicators of the prognosis of TTTS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A better guideline for twin-to-twin-transfusion syndrome are anticipated to be established in&#xD;
      China. Fetoscopic laser surgery is applied to treat TTTS. After surgery, better prediction&#xD;
      indicators of the prognosis of TTTS are needed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Weight in kilogram of neonate</measure>
    <time_frame>At birth of neonate</time_frame>
    <description>Including twin pregnancy of TTTS after fetoscopic laser surgery measured by nurses</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopment at early childhood</measure>
    <time_frame>At age of 1 year old</time_frame>
    <description>Including adaptive, gross motor, fine motor, language, and social function; assessed using Gesell Developmental Schedules.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Twin Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        TTTS after fetoscopic laser surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        TTTS after fetoscopic laser surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Pregnant women who refuse to take part in the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shengjing Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>June 27, 2021</last_update_submitted>
  <last_update_submitted_qc>June 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shengjing Hospital</investigator_affiliation>
    <investigator_full_name>Caixia Liu</investigator_full_name>
    <investigator_title>Director of the second obstetrical department</investigator_title>
  </responsible_party>
  <keyword>TTTS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetofetal Transfusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

